Carlyle makes a partial exit from IPO-bound Indegene

Private equity firm Carlyle has trimmed its stake in Indegene, just two years after teaming up with another investment firm to joint betting $200 million (Rs 1,500 crore then) on the healthtech venture.  Carlyle had joined hands with Brighton Park Capital, a private investment firm that focuses on software, information services, ......